
Patrik Jonsson, executive vice president and president, Lilly International, will retire at the end of 2026

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes

The deal focuses on addressing critical unmet medical needs

Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK

The acquisition is to advance treatments for serious autoimmune and allergic diseases

The UK is the first country in Europe to authorise the oral medication

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually

The acquisition will advance therapies for treatment-resistant depression and other mental health conditions

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form

SPMS is a debilitating stage of MS where patients experience increasing levels of disability

Fontoura previously held senior leadership roles at Xaira Therapeutics and Roche

It is the first anticancer treatment in the UK and globally to be administered this way and a first in multiple myeloma